1.
Proteasome inhibitors: beyond NFKB inhibition alone and the emerging role of combination therapy in the treatment of multiple myeloma. Hematol Meeting Rep [Internet]. 2009 Jun. 23 [cited 2025 Jul. 12];2(5). Available from: https://journals.pagepress.org/hmr/article/view/753